MediXall (MDXL) EPS (Basic) (2019 - 2024)
MediXall's EPS (Basic) history spans 8 years, with the latest figure at $0.0 for Q3 2024.
- For Q3 2024, EPS (Basic) rose 115.93% year-over-year to $0.0; the TTM value through Sep 2024 reached -$0.01, up 75.0%, while the annual FY2023 figure was -$0.04, 33.33% up from the prior year.
- EPS (Basic) reached $0.0 in Q3 2024 per MDXL's latest filing, up from -$0.0 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.0 in Q3 2024 to a low of -$0.03 in Q4 2020.
- Average EPS (Basic) over 5 years is -$0.01, with a median of -$0.01 recorded in 2020.
- Peak YoY movement for EPS (Basic): crashed 100.0% in 2021, then soared 115.93% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.03 in 2020, then surged by 40.73% to -$0.02 in 2021, then skyrocketed by 43.76% to -$0.01 in 2022, then dropped by 0.0% to -$0.01 in 2023, then skyrocketed by 115.93% to $0.0 in 2024.
- Per Business Quant, the three most recent readings for MDXL's EPS (Basic) are $0.0 (Q3 2024), -$0.0 (Q2 2024), and -$0.0 (Q1 2024).